HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade.
A. Prat, T. Pascual, C. De Angelis, C. Gutierrez, A. Llombart-Cussac, Tao Wang, J. Cortés, B. Rexer, L. Paré, A. Forero, A. Wolff, S. Morales, B. Adamo, F. Brasó-Maristany, M. Vidal, J. Veeraraghavan, I. Krop, P. Galván, A. Pavlick, B. Bermejo, M. Izquierdo, V. Rodrik-Outmezguine, J. Reis-Filho, S. Hilsenbeck, Mafalda Oliveira, M. Dieci, G. Griguolo, R. Fasani, P. Nuciforo, J. Parker, P. Conte, R. Schiff, V. Guarneri, C. Osborne, M. Rimawi
Journal of the National Cancer Institute